Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-04-14 am EDT			5-day change	1st Jan Change
1,843.00 ^DKK	+2.65%		+5.22%	-9.08%

Apr. 14	Genmab A/S Provides Net Sales of Darzalex Results for the First Quarter of 2026	CI
Apr. 14	Genmab Posts Higher Darzalex Net Sales in Q1	MT

Transcript : Genmab A/S Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 01

Published on 03/11/2026 at 02:35 pm EDT - Modified on 03/11/2026 at 02:50 pm EDT

S&P Capital IQ

Presenter Speech
James Gordon (Analysts)

Good afternoon, everyone. Thanks for joining. I'm James Gordon, Barclay's European pharma and biotech analyst. And it's my pleasure this afternoon to host a

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Genmab A/S

Apr. 14	Genmab A/S Provides Net Sales of Darzalex Results for the First Quarter of 2026	CI
Apr. 14	Genmab Posts Higher Darzalex Net Sales in Q1	MT
Apr. 14	Genmab Reports Q1 Net Sales of DARZALEX	MT
Apr. 14	Genmab reports Darzalex sales of $3.96 billion in Q1	FW
Apr. 14	Genmab Q1 Darzalex net sales at $3,964 mln	RE
Apr. 14	Jyske Bank upgrades Genmab to Buy from Hold, sets price target at DKK 2,300 - BN	FW
Apr. 14	Genmab Combo Therapy Shows Safe Profile in Ovarian Cancer Trial	MT
Apr. 13	Genmab Says Rinatabart Sesutecan Combination Tolerable in Patients With Advanced Ovarian Cancer	MT
Apr. 13	Genmab reports promising safety data in clinical trial	FW
Apr. 13	Genmab says phase 1/2 Rainfol-01 data show Rina-S and bevacizumab combination tolerable	RE
Apr. 13	Genmab A/S Presents Safety And Tolerability Data Of Rinatabart Sesutecan (Rina-S) In Combination With Bevacizumab In Advanced Ovarian Cancer	CI
Apr. 10	Nordic Equities in North America - Ericsson slips 0.5 percent	FW
Apr. 09	Nordic Equities in North America - Autoliv slips 0.7 percent	FW
Apr. 07	Nordic Stocks in North America - Astra Zeneca rose 2.1 percent	FW
Apr. 02	Nordic Stocks in North America - AstraZeneca Gains 1.8 Percent	FW